Insider · CIK 0002068746
Lynette Holzbaur
Files at OGN (Organon & Co.). First filing May 7, 2026, latest May 7, 2026.
In brief
Lynette Holzbaur files SEC Form 4 as officer at OGN (Organon & Co.). Since May 7, 2026, Lynette Holzbaur has reported 1 open-market buy worth $353k and 1 open-market sell worth $353k, the latest filed on May 7, 2026.
A track record needs three past buys with six months of prices behind them; Lynette Holzbaur has 0, so none is measured yet.
The newest scored trade: bought $353k of OGN on May 6, 2026, filed May 7, 2026, scored 40 (moderate). In the last 12 months: 1 buy worth $353k and 1 sell worth $353k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OGN: Organon & Co.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | OGNbuy Organon & Co. | $353k 26,448 shares | +100% | +135% from low0% from high | |
| 50Moderate | OGNsell Organon & Co. | $353k 26,448 shares | -100% | +135% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 8, 2026 | OGN Organon & Co. | 26,448 0.01% of outstanding | $353k | May 6, 2026 | none |
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | OGN Organon & Co. | JOther Common Stock | +46 | $0.00 | $0 | 26,448 | May 7, 2026 |
| May 6, 2026 | OGN Organon & Co. | POpen-market purchase Common Stock | +26,448 | $13.35 | $353k | 52,851 | May 7, 2026 |
| May 6, 2026 | OGN Organon & Co. | SOpen-market sale Common Stock | -26,448 | $13.35 | $353k | 0 | May 7, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | MOption exercise Common Stock | +4,252 | $0.00 | $0 | 22,813 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | FTax withholding Common Stock | -1,212 | $5.70 | $6,908 | 21,601 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | MOption exercise Common Stock | +6,715 | $0.00 | $0 | 28,316 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | FTax withholding Common Stock | -1,914 | $5.70 | $11k | 26,402 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | AGrant or award Restricted Stock Unitsderivative | +75,125 | $0.00 | $0 | 75,125 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | AGrant or award Restricted Stock Unitsderivative | +41,736 | $0.00 | $0 | 41,736 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -4,252 | $0.00 | $0 | 0 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -6,715 | $0.00 | $0 | 0 | Apr 2, 2026 |
| Mar 29, 2026 | OGN Organon & Co. | MOption exercise Common Stock | +5,319 | $0.00 | $0 | 19,995 | Mar 31, 2026 |
| Mar 29, 2026 | OGN Organon & Co. | FTax withholding Common Stock | -1,516 | $5.84 | $8,853 | 18,561 | Mar 31, 2026 |
| Mar 29, 2026 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -5,319 | $0.00 | $0 | 5,319 | Mar 31, 2026 |
| Nov 7, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +2,417 | $0.00 | $0 | 15,365 | Nov 10, 2025 |
| Nov 7, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -689 | $6.71 | $4,623 | 14,676 | Nov 10, 2025 |
| Nov 7, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -2,417 | $0.00 | $0 | 2,418 | Nov 10, 2025 |
| Nov 5, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +3,037 | $0.00 | $0 | 13,814 | Nov 6, 2025 |
| Nov 5, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -866 | $6.52 | $5,646 | 12,948 | Nov 6, 2025 |
| Nov 5, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -3,037 | $0.00 | $0 | 6,076 | Nov 6, 2025 |
Questions about Lynette Holzbaur
Answered from the filings on this page, as of the latest one.
Is Lynette Holzbaur buying or selling?
In the last 12 months Lynette Holzbaur reported 1 open-market buy worth $353k and 1 open-market sell worth $353k on SEC Form 4; the latest was bought $353k of OGN on May 6, 2026. Grants, option exercises and tax withholding are not counted.
How did Lynette Holzbaur's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lynette Holzbaur has 0.
Where does Lynette Holzbaur file Form 4?
Lynette Holzbaur has filed Form 4 at OGN (Organon & Co.) as SVP and Corporate Controller. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.